PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
14-Oct-2024 Sanofi in discussions to sell a controlling stake in Opella Sanofi
14-Oct-2024 CNX Therapeutics CEO Guy Clark Awarded “CEO of the Year” at CPHI Pharma Awards CNX Therapeutics
14-Oct-2024 HONEYWELL TECHNOLOGY TO POWER DEVPRO BIOPHARMA’S NEXT-GENERATION LOW-EMISSION RESPIRATORY INHALER Honeywell
14-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Ltd
14-Oct-2024 GSK and ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024 GSK
14-Oct-2024 EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model EVERSANA
11-Oct-2024 The Top Clinical Research Courses for Beginners Fusion Technology Solutions
10-Oct-2024 CNX Therapeutics CEO Guy Clark Awarded “CEO of the Year” at CPHI Pharma Awards CNX Therapeutics
10-Oct-2024 Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation Pharming Group
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Valneva Scotland supports local cancer charity Team Jak Foundation Valneva Scotland
10-Oct-2024 NICE lifts restriction and recommends bispecific antibody TECVAYLI®▼ (teclistamab) for all eligible patients with relapsed and refractory multiple myeloma after three treatments Johnson & Johnson
10-Oct-2024 Demonstrating the potential of flow biocatalysis Vapourtec
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology Aenitis
10-Oct-2024 New Study Demonstrates Scalp Cooling Efficacy in Reducing Persistent Chemotherapy-Induced Alopecia Paxman
10-Oct-2024 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer FluoGuide A/S
10-Oct-2024 Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public GWI research
10-Oct-2024 Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer Curve Therapeutics
10-Oct-2024 Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687 Antag Therapeutics